electroCore strengthens its patent portfolio with the issuance of four new US patents

electroCore strengthens its patent portfolio with the issuance of four new US patents

ROCKAWAY, NJ, Sept. 21, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark Office (USPTO ) has issued four patents related to its noninvasive vagus nerve stimulation (nVNS) and other technologies, including the following patents: U.S. Patent No. 11,406,825 entitled “Mobile Phone …

electroCore strengthens its patent portfolio with the issuance of four new US patents Read More »